BIONTECH SE ($BNTX) posted quarterly earnings results on Monday, May 5th. The company reported earnings of -$1.60 per share, beating estimates of -$2.13 by $0.53. The company also reported revenue of $169,493,220, missing estimates of $180,945,684 by $-11,452,464.
You can see Quiver Quantitative's $BNTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIONTECH SE Hedge Fund Activity
We have seen 136 institutional investors add shares of BIONTECH SE stock to their portfolio, and 142 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 1,401,547 shares (+22.2%) to their portfolio in Q4 2024, for an estimated $159,706,280
- VIKING GLOBAL INVESTORS LP added 894,556 shares (+1932.3%) to their portfolio in Q4 2024, for an estimated $101,934,656
- BANK OF NEW YORK MELLON CORP added 694,691 shares (+18892.9%) to their portfolio in Q1 2025, for an estimated $63,258,562
- BALYASNY ASSET MANAGEMENT L.P. removed 620,466 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $70,702,100
- BNP PARIBAS FINANCIAL MARKETS added 614,297 shares (+inf%) to their portfolio in Q4 2024, for an estimated $69,999,143
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 433,388 shares (+632.6%) to their portfolio in Q4 2024, for an estimated $49,384,562
- UBS GROUP AG added 406,072 shares (+330.2%) to their portfolio in Q4 2024, for an estimated $46,271,904
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BIONTECH SE Analyst Ratings
Wall Street analysts have issued reports on $BNTX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Evercore ISI issued a "Outperform" rating on 11/19/2024
- Leerink Partners issued a "Outperform" rating on 11/13/2024
- Goldman Sachs issued a "Buy" rating on 11/08/2024
To track analyst ratings and price targets for BIONTECH SE, check out Quiver Quantitative's $BNTX forecast page.
BIONTECH SE Price Targets
Multiple analysts have issued price targets for $BNTX recently. We have seen 4 analysts offer price targets for $BNTX in the last 6 months, with a median target of $131.0.
Here are some recent targets:
- An analyst from H.C. Wainwright set a target price of $145.0 on 04/01/2025
- Cory Kasimov from Evercore ISI set a target price of $125.0 on 11/19/2024
- Daina Graybosch from Leerink Partners set a target price of $121.0 on 11/13/2024
- Chris Shibutani from Goldman Sachs set a target price of $137.0 on 11/08/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
